Anika Therapeutics, Inc.ANIKNASDAQ

Revenue (LTM)

$113M

-5.9% YoY

Net Income (LTM)

$-11M

+80.7% YoY

Free Cash Flow

$4M

Revenue CAGR (5Y)

-6.5%

Marginsimproving

FCFTurned positive

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	148	114↓23.0%	121↑6.1%	120↓0.7%	113↓5.9%
Gross Profit	83	73↓11.7%	83↑12.7%	76↓7.9%	64↓16.0%
Operating Income	3	4↑40.3%	1↓77.0%	-5↓704.4%	-11↓116.6%
Net Income	4	-15↓459.4%	-83↓456.3%	-56↑31.8%	-11↑80.7%
EBITDA	-4	18↑536.2%	15↓17.1%	3↓79.9%	-2↓160.7%
EPS Diluted	0.28	-1.02↓464.3%	-5.64↓452.9%	-3.83↑32.1%	-0.76↑80.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	94	86↓8.5%	69↓20.4%	56↓19.1%	57↑3.3%
Total Current Assets	169	170↑0.6%	163↓3.7%	114↓30.4%	103↓9.1%
Total Assets	348	349↑0.5%	271↓22.5%	203↓25.1%	190↓6.2%
Total Current Liabilities	30	28↓6.3%	31↑11.3%	23↓25.0%	22↓6.0%
Total Liabilities	60	64↑5.2%	58↓8.2%	49↓16.5%	47↓4.0%
Total Equity	287	286↓0.5%	212↓25.7%	154↓27.5%	143↓6.8%
Total Debt	21	31↑47.4%	28↓10.2%	26↓6.5%	24↓6.7%
Net Debt	-73	-55↑24.5%	-41↑26.0%	-30↑27.6%	-33↓12.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	8	4↓47.5%	-2↓140.6%	5↑402.2%	11↑107.1%
Capital Expenditure	-5	-7↓45.6%	-5↑27.5%	-8↓42.5%	-7↑11.7%
Free Cash Flow	3	-3↓194.6%	-7↓134.5%	-2↑67.7%	4↑287.1%
Stock-Based Comp	11	14↑29.1%	15↑6.5%	13↓13.9%	10↓23.2%
Net Change in Cash	-1	-8↓463.2%	-13↓67.0%	-16↓16.7%	0↑102.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance